NCT00003264View on ClinicalTrials.gov

Cisplatin Plus Gemcitabine in Treating Patients With Advanced Squamous Cell Head and Neck Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

October 31, 1997

Primary Completion Date

February 28, 2002

Study Completion Date

June 30, 2002

Conditions
Head and Neck Cancer
Interventions
DRUG

cisplatin

DRUG

gemcitabine hydrochloride

Trial Locations (12)

17101

Harrisburg Polyclinic Medical Center, Harrisburg

18015

St. Luke's Network - Bethlehem, Bethlehem

19026

Delaware County Memorial Hospital, Drexel Hill

19047

Saint Mary Regional Center, Langhorne

19111

Fox Chase Cancer Center, Philadelphia

08822

Hunterdon Regional Cancer Center, Flemington

08060

Fox Chase Cancer Center at Virtua Memorial Hospital Burlington County, Mount Holly

07701

Riverview Medical Center - Booker Cancer Center, Red Bank

08629

St. Francis Medical Center, Trenton

19446-1200

North Penn Hospital, Lansdale

19301-1792

Paoli Memorial Hospital, Paoli

19612-6052

Reading Hospital and Medical Center, Reading

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Fox Chase Cancer Center

OTHER

NCT00003264 - Cisplatin Plus Gemcitabine in Treating Patients With Advanced Squamous Cell Head and Neck Cancer | Biotech Hunter | Biotech Hunter